MEDICURE INC
MCUJF$8M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaWINNIPEG
Drugs in Pipeline
5
Phase 3 Programs
2
Upcoming Catalysts
1
Next Catalyst
Nov 15, 2026
35wMarket Overview
Stock performance and key metrics
MCUJF News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
(MC-1) Pyridoxal 5'-phosphate
Coronary Artery Bypass Graft Surgery
Pyridoxal Phosphate
Pyridox(am)Ine 5'-Phosphate Oxidase Deficiency
Short Tirofiban
Myocardial Infarction
(MC-1) Pyridoxal-5'-phosphate
Coronary Artery Bypass Graft Surgery
pyridoxal-5'-phosphate with and without ACE inhibitor
Diabetes Mellitus Type 2
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
(MC-1) Pyridoxal 5'-phosphate | Phase 3 | Coronary Artery Bypass Graft Surgery | - | - |
Pyridoxal Phosphate | Phase 3 | Pyridox(am)Ine 5'-Phosphate Oxidase Deficiency | - | - |
Short Tirofiban | Phase 2 | Myocardial Infarction | - | - |
(MC-1) Pyridoxal-5'-phosphate | Phase 2 | Coronary Artery Bypass Graft Surgery | - | - |
pyridoxal-5'-phosphate with and without ACE inhibitor | Phase 2 | Diabetes Mellitus Type 2 | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply